Arrivent Biopharma (NASDAQ: AVBP) reported Q4 2023 earnings per share (EPS) of -$7.69, up 5.76% year over year. Total Arrivent Biopharma earnings for the quarter were -$21.19 million. In the same quarter last year, Arrivent Biopharma's earnings per share (EPS) was -$8.16.
As of Q2 2024, Arrivent Biopharma's earnings has grown year over year. Arrivent Biopharma's earnings in the past year totalled -$69.33 million.
What was AVBP's revenue last quarter?
Arrivent Biopharma (NASDAQ: AVBP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Arrivent Biopharma's revenue was $0.00.
What was AVBP's revenue growth in the past year?
As of Q2 2024, Arrivent Biopharma's revenue has grown null year over year. Arrivent Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.